Literature DB >> 17274788

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

A Blenkinsopp1, P Wilkie, M Wang, P A Routledge.   

Abstract

AIMS: To synthesize data from published studies and international experience to identify evidence of potential benefits and drawbacks of direct patient reporting of suspected adverse drug reactions (ADRs) by patients.
METHODS: Structured search of MEDLINE, CINAHL and PsycINFO supplemented by internet searches and requests for information to key contacts.
RESULTS: Seven studies (eight papers) were included in the review. None of the studies concerned spontaneous reporting by patients. Information on patient reporting systems was obtained for six countries, with summary data reported by four. Patient reports identified possible new ADRs that had not previously been reported by health professionals. The quality of patient reports appears to be similar to that of health professional reports. There is some evidence that patients report an ADR when they consider their health professional has not paid attention to their concerns. Patient reports may, at least initially, be more time consuming to process.
CONCLUSIONS: Overall, the evidence indicates that patient reporting of suspected ADRs has more potential benefits than drawbacks. Evaluation of patient reporting systems is needed to provide further evidence.

Entities:  

Mesh:

Year:  2007        PMID: 17274788      PMCID: PMC2000570          DOI: 10.1111/j.1365-2125.2006.02746.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Antidepressants and adverse effects in young patients: uncovering the evidence.

Authors:  Andrew Herxheimer; Barbara Mintzes
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

2.  Consumer groups look to improve adverse event reporting systems.

Authors:  Brian Vastag
Journal:  J Natl Cancer Inst       Date:  2005-12-21       Impact factor: 13.506

3.  Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital.

Authors:  Monica B Aspinall; Jeff Whittle; Sherrie L Aspinall; Robert L Maher; Chester B Good
Journal:  Am J Health Syst Pharm       Date:  2002-05-01       Impact factor: 2.637

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Patient reporting of potential adverse drug reactions: a methodological study.

Authors:  N Jarernsiripornkul; J Krska; P A G Capps; R M E Richards; A Lee
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

6.  Reporting adverse drug reactions on a geriatric ward: a pilot project.

Authors:  Annemie Somers; Mirko Petrovic; Hugo Robays; Marc Bogaert
Journal:  Eur J Clin Pharmacol       Date:  2003-02-11       Impact factor: 2.953

Review 7.  Consumer adverse drug reaction reporting: a new step in pharmacovigilance?

Authors:  Kees van Grootheest; Linda de Graaf; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Patient reporting of adverse drug reactions: useful information for pain management?

Authors:  Narumol Jarernsiripornkul; Janet Krska; R Michael E Richards; Phillip A G Capps
Journal:  Eur J Pain       Date:  2003       Impact factor: 3.931

Review 9.  Patients' role in reporting adverse drug reactions.

Authors:  Kees van Grootheest; Lolkje de Jong-van den Berg
Journal:  Expert Opin Drug Saf       Date:  2004-07       Impact factor: 4.250

10.  Patients as a direct source of information on adverse drug reactions.

Authors:  A S Mitchell; D A Henry; R Sanson-Fisher; D L O'Connell
Journal:  BMJ       Date:  1988-10-08
View more
  106 in total

Review 1.  Experiences with adverse drug reaction reporting by patients: an 11-country survey.

Authors:  Florence van Hunsel; Linda Härmark; Shanthi Pal; Sten Olsson; Kees van Grootheest
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  Comparing adverse event rates of oral blood glucose-lowering drugs reported by patients and healthcare providers: a post-hoc analysis of observational studies published between 1999 and 2011.

Authors:  Liana Hakobyan; Flora M Haaijer-Ruskamp; Dick de Zeeuw; Daniela Dobre; Petra Denig
Journal:  Drug Saf       Date:  2011-12-01       Impact factor: 5.606

3.  How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme.

Authors:  Janet Krska; Claire Anderson; Elizabeth Murphy; Anthony J Avery
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

4.  Predicting adverse drug events from personal health messages.

Authors:  Brant W Chee; Richard Berlin; Bruce Schatz
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

5.  Adverse drug reactions: analysis of spontaneous reporting system in Europe in 2007-2009.

Authors:  Jindrich Srba; Veronika Descikova; Jiri Vlcek
Journal:  Eur J Clin Pharmacol       Date:  2012-02-01       Impact factor: 2.953

6.  Consumers' reports of suspected adverse drug reactions volunteered to a consumer magazine.

Authors:  Lise Aagaard; Ebba Holme Hansen
Journal:  Br J Clin Pharmacol       Date:  2010-03       Impact factor: 4.335

7.  Community pharmacists' views on adverse drug reactions reporting in Malaysia: a pilot study.

Authors:  Kang-Nee Ting; Dane Michael Stratton-Powell; Claire Anderson
Journal:  Pharm World Sci       Date:  2010-03-25

8.  Adverse drug reactions--no farewell to harms.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

9.  The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective.

Authors:  Claire Anderson; Janet Krska; Elizabeth Murphy; Anthony Avery
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

10.  The Role of European Patient Organizations in Pharmacovigilance.

Authors:  Cristiano Matos; Gerda Weits; Florence van Hunsel
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.